Form 8-K - Current report:
SEC Accession No. 0001564590-21-014020
Filing Date
2021-03-18
Accepted
2021-03-18 08:31:42
Documents
61
Period of Report
2021-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agle-8k_20210318.htm   iXBRL 8-K 44970
2 EX-99.1 agle-ex991_6.htm EX-99.1 247282
3 EX-99.2 agle-ex992_123.htm EX-99.2 55692
4 GRAPHIC slide-eovv43nrvlq.jpg GRAPHIC 66662
5 GRAPHIC slide-3hsbswr1gw2.jpg GRAPHIC 53715
6 GRAPHIC slide-badgnox0ksl.jpg GRAPHIC 53964
7 GRAPHIC slide-b34hjrr351d.jpg GRAPHIC 62125
8 GRAPHIC slide-y2upb5yyy4j.jpg GRAPHIC 19960
9 GRAPHIC slide-0prd4w5bmhz.jpg GRAPHIC 62546
10 GRAPHIC slide-tbgd1gbrsmj.jpg GRAPHIC 66008
11 GRAPHIC slide-e3ixgonjfwi.jpg GRAPHIC 53458
12 GRAPHIC slide-tqp21u204gq.jpg GRAPHIC 62784
13 GRAPHIC slide-kbfnl3t2j5a.jpg GRAPHIC 48883
14 GRAPHIC slide-2cnhrn3bzj3.jpg GRAPHIC 45717
15 GRAPHIC slide-u3jzxhiesff.jpg GRAPHIC 63473
16 GRAPHIC slide-qy5fefjp3iv.jpg GRAPHIC 16358
17 GRAPHIC slide-qzcghtjiqq4.jpg GRAPHIC 60918
18 GRAPHIC slide-v4q2u2f4zrx.jpg GRAPHIC 51316
19 GRAPHIC slide-jlqryz3cl03.jpg GRAPHIC 54248
20 GRAPHIC slide-dslyrqf3uxz.jpg GRAPHIC 36650
21 GRAPHIC slide-ec5mj4y1mob.jpg GRAPHIC 60605
22 GRAPHIC slide-ia1jlwxtmba.jpg GRAPHIC 48248
23 GRAPHIC slide-njiprv4m3xc.jpg GRAPHIC 56224
24 GRAPHIC slide-ajm3jzbbmmp.jpg GRAPHIC 32192
25 GRAPHIC slide-wwocxucrrqq.jpg GRAPHIC 52978
26 GRAPHIC slide-fq00dghx3re.jpg GRAPHIC 65238
27 GRAPHIC slide-hzpmqakbsuc.jpg GRAPHIC 76870
28 GRAPHIC slide-xjf4iz0gvn4.jpg GRAPHIC 67995
29 GRAPHIC slide-nzzbzv0i2d4.jpg GRAPHIC 18027
30 GRAPHIC slide-a0ayy1xex0b.jpg GRAPHIC 66335
31 GRAPHIC slide-yl04mqsseu4.jpg GRAPHIC 29146
32 GRAPHIC slide-jvy4vswliwh.jpg GRAPHIC 105159
33 GRAPHIC slide-mfryu4tvlqa.jpg GRAPHIC 56542
34 GRAPHIC slide-lyp3kb5hhjm.jpg GRAPHIC 57838
35 GRAPHIC slide-gouygecl2as.jpg GRAPHIC 66939
36 GRAPHIC slide-213kiqmlsom.jpg GRAPHIC 50213
37 GRAPHIC slide-feerk5fpkra.jpg GRAPHIC 49541
38 GRAPHIC slide-izsz2oc3p2p.jpg GRAPHIC 46781
39 GRAPHIC slide-wrk4fgoswzt.jpg GRAPHIC 51810
40 GRAPHIC slide-mo2q5dxrz0e.jpg GRAPHIC 42023
41 GRAPHIC slide-v3o1cyxivkq.jpg GRAPHIC 76167
42 GRAPHIC ghnj2ghmswlp000001.jpg GRAPHIC 9332
43 GRAPHIC slide-oyh1sk453qq.jpg GRAPHIC 43354
44 GRAPHIC slide-jr4tuhgw3fp.jpg GRAPHIC 52042
45 GRAPHIC slide-m3ktmcrtia3.jpg GRAPHIC 61202
46 GRAPHIC slide-cwzbioxl30b.jpg GRAPHIC 18143
47 GRAPHIC slide-zkwoimmv5mr.jpg GRAPHIC 56256
48 GRAPHIC slide-qjhshjtvmyq.jpg GRAPHIC 20506
49 GRAPHIC slide-azs1zqtjshz.jpg GRAPHIC 56760
50 GRAPHIC slide-4xxdn155u3m.jpg GRAPHIC 51611
  Complete submission text file 0001564590-21-014020.txt   3864317

Data Files

Seq Description Document Type Size
51 XBRL TAXONOMY EXTENSION SCHEMA agle-20210318.xsd EX-101.SCH 5764
52 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20210318_lab.xml EX-101.LAB 20227
53 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20210318_pre.xml EX-101.PRE 12075
54 EXTRACTED XBRL INSTANCE DOCUMENT agle-8k_20210318_htm.xml XML 3689
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 21753179
SIC: 2834 Pharmaceutical Preparations